Skip to main content

Supply Support for Oncology Providers

MediCore works with hospital pharmacy departments, oncology treatment centres, and specialist pharmacies across Nigeria to ensure consistent access to essential chemotherapy and specialty medicines. We understand that treatment continuity depends on supply reliability, and our distribution model is built around that principle.

Our team coordinates supply against clinical demand patterns, works to anticipate procurement needs, and maintains communication with hospital pharmacy teams to minimise the risk of stock shortages that can disrupt patient treatment schedules.

Oncology and Specialty Medicine Focus

Unlike general pharmaceutical distributors, MediCore focuses exclusively on oncology and specialty medicines. This means we understand the clinical context of the products we supply: the treatment protocols they support, the urgency of supply requirements, and the handling standards they demand.

Our portfolio covers the core therapeutic categories used in Nigerian cancer care, from platinum-based chemotherapy and taxanes to supportive medicines and oral therapies. All products are sourced from EU-GMP and WHO-GMP accredited manufacturers.

View our full product portfolio →

Why Procurement Teams Choose MediCore

Product Quality Assurance

Every product we supply is sourced from EU-GMP or WHO-GMP accredited manufacturers with full documentation. Hospital pharmacy teams can be confident in the provenance and quality of medicines received from MediCore.

Supply Reliability

We coordinate supply against clinical demand patterns and maintain stock levels designed to support consistent treatment delivery. Our logistics are managed to minimise delivery delays and supply gaps.

Regulatory Compliance

MediCore operates under a PCN wholesale distribution licence with pharmacist-supervised handling. Hospital procurement teams can be confident that their supply chain meets regulatory requirements.

Oncology Expertise

Our oncology focus means we understand treatment protocols, prescribing patterns, and the practical supply challenges that hospital oncology departments face. We speak your language.

Dedicated Support

Each hospital and oncology centre relationship is managed with a clear point of contact for supply enquiries, order coordination, and product availability information.

Flexible Procurement

We work within your existing procurement frameworks, whether through direct purchase orders, tender processes, or institutional supply agreements. Our approach adapts to your requirements.

Our Reliability Commitment

Cancer treatment cannot wait for supply chain problems to be resolved. MediCore's distribution model is designed to provide the supply consistency that oncology providers need:

  • Proactive demand monitoring and stock management
  • Direct relationships with accredited international manufacturers
  • Transparent communication about product availability and lead times
  • Documented batch traceability from manufacturer to hospital
  • Pharmacist-supervised storage and dispatch processes

How to Start a Supply Discussion

If you are a hospital pharmacy director, procurement manager, or oncology centre administrator interested in discussing oncology medicine supply with MediCore, the process is straightforward:

  1. Contact our team via the enquiry form or by phone to discuss your requirements.
  2. We will arrange a confidential supply discussion to understand your product needs, delivery requirements, and procurement processes.
  3. MediCore will provide product availability information and a supply proposal tailored to your facility.
  4. Once agreed, we establish regular supply coordination and ongoing communication.

Discuss Your Oncology Supply Requirements

Contact MediCore to discuss how we can support your hospital or oncology centre with reliable access to essential chemotherapy and specialty medicines.